WPI 3355 Pill - pink capsule/oblong, 17mm
Pill with imprint WPI 3355 is Pink, Capsule/Oblong and has been identified as Nateglinide 120 mg. It is supplied by Watson Laboratories Inc.
Nateglinide is used in the treatment of Type 2 Diabetes and belongs to the drug class meglitinides. Risk cannot be ruled out during pregnancy. Nateglinide 120 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for WPI 3355
Nateglinide
- Imprint
- WPI 3355
- Strength
- 120 mg
- Color
- Pink
- Size
- 17.00 mm
- Shape
- Capsule/Oblong
- Availability
- Prescription only
- Drug Class
- Meglitinides
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Watson Laboratories Inc.
- National Drug Code (NDC)
- 00591-3355
- Inactive Ingredients
-
silicon dioxide,
fumaric acid,
hypromellose 2910 (3 mPa.s),
lactose monohydrate,
magnesium stearate,
polysorbate 80,
sodium starch glycolate type A potato,
corn starch,
titanium dioxide,
hypromellose 2910 (6 mPa.s),
FD&C Red No. 40,
ferric oxide red,
ferrosoferric oxide
Note: Inactive ingredients may vary.
See also:
More about nateglinide
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (5)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- Drug class: meglitinides
- Breastfeeding
- En español
Patient resources
Other brands
Professional resources
Other brands
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.